P. Ortiz

Wayne State University — United States

Medicine · Health Sciences

27h-index4.2kcitations81works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(20), Folate and B Vitamins Research(16), Sulfur Compounds in Biology(11), Metabolism and Genetic Disorders(7), Metabolomics and Mass Spectrometry Studies(6)

Publications80 total

Interdisciplinary study of 16th-century Spanish court woman fashion, gemstones, and Virgen del Rosario dress
npj Heritage Science·2025Open Access
Abstract Fri118: Prostaglandin E2 Alters Cardiac Metabolism via its EP3 Receptor
Circulation Research·2025
Teaching oral and maxillofacial pathology and oral medicine in undergraduate and postgraduate in Latin America
Medicina oral, patología oral y cirugía bucal·2025· 4 citedOpen Access
Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Hepatology·2024· 2 citedOpen Access
Abstract P331: Simple Instruction and Provision of Literature on Low Salt Diet Ineffective in Reducing Salt Intake in Patients with Hypertension
Hypertension·2024
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Hepatology·2023· 65 citedOpen Access
Supplementary Data from A High-Throughput Study in Melanoma Identifies Epithelial-Mesenchymal Transition as a Major Determinant of Metastasis
2023Open Access
Lipidomic Profiling in Clinical Practice Using LC-MS
2023
Bringing Human Serum Lipidomics to the Forefront of Clinical Practice: Two Clinical Diagnosis Success Stories
2023
Abstract 13440: Effect of Pemvidutide (ALT-801), a Novel GLP-1/Glucagon Dual Receptor Agonist, on Pathogenic Lipid Mediators
Circulation·2022· 1 cited
Influence of pregnancy on NAFLD-associated lipidomic signatures
Journal of Hepatology·2022
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Nature Reviews Gastroenterology & Hepatology·2021· 416 cited
Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122
Gastroenterology·2020· 85 citedOpen Access
Mo1456 UTILITY OF METABOLOMIC BIOMARKERS TO IDENTIFY NONALCOHOLIC FATTY LIVER DISEASE IN LIVER TRANSPLANT RECIPIENTS
Gastroenterology·2020
Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis
Journal of Hepatology·2020· 261 citedOpen Access
Emerging Circulating Biomarkers for The Diagnosis and Assessment of Treatment Responses in Patients with Hepatic Fat Accumulation, Nash and Liver Fibrosis
2019· 6 cited
Systemic rituximab in the treatment of indolent primary cutaneous B-cell lymphomas
European Journal of Cancer·2019
PSS45 - A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.
Value in Health·2018
Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts
Hepatology Communications·2018· 156 citedOpen Access
Use of a metabolomic approach to non‐invasively diagnose non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus
Diabetes Obesity and Metabolism·2018· 49 cited
page 1 of 4Next →

Frequent Co-authors

José M. Mato(16), Marı́a A. Pajares(5), Cristina Alonso(5), Carmen Cabrero(5), J.P. De La Cruz(5), Fernando J. Corrales(5), Felipe Sánchez de la Cuesta(5), Antonio Martín‐Duce(4), Jose Luis Puerta(4), Antonio Martín Duce(4), Ibon Martínez‐Arranz(4), José Antonio González Correa(4), Javier Cámara(3), Quentin M. Anstee(3), Mazen Noureddin(3), Susana Sánchez‐Fidalgo(3), Catalina Alarcón‐de‐la‐Lastra(3), Virginia Motilva(3), M.J. Martín(3), Javier Segovia(3)